In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.
Wu, N.C., Grande, G., Turner, H.L., Ward, A.B., Xie, J., Lerner, R.A., Wilson, I.A.(2017) Nat Commun 8: 15371-15371
- PubMed: 28504265 
- DOI: 10.1038/ncomms15371
- Primary Citation of Related Structures:  
5UMN - PubMed Abstract: 
The relatively recent discovery and characterization of human broadly neutralizing antibodies (bnAbs) against influenza virus provide valuable insights into antiviral and vaccine development. However, the factors that influence the evolution of high-affinity bnAbs remain elusive ...